Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-067771
Filing Date
2024-08-12
Accepted
2024-08-12 17:16:27
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210364-10q_therap.htm   iXBRL 10-Q 528443
2 CERTIFICATION ea021036401ex31-1_therap.htm EX-31.1 9497
3 CERTIFICATION ea021036401ex31-2_therap.htm EX-31.2 9500
4 CERTIFICATION ea021036401ex32-1_therap.htm EX-32.1 4286
5 CERTIFICATION ea021036401ex32-2_therap.htm EX-32.2 4292
  Complete submission text file 0001213900-24-067771.txt   4139818

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE txmd-20240630.xsd EX-101.SCH 49511
7 XBRL CALCULATION FILE txmd-20240630_cal.xml EX-101.CAL 41125
8 XBRL DEFINITION FILE txmd-20240630_def.xml EX-101.DEF 218871
9 XBRL LABEL FILE txmd-20240630_lab.xml EX-101.LAB 398765
10 XBRL PRESENTATION FILE txmd-20240630_pre.xml EX-101.PRE 216681
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0210364-10q_therap_htm.xml XML 416865
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 241197935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)